Dr. Reddy’s unveils montelukast sodium oral granules
According to IMS Health, the Singulair granules had sales of nearly $61m in the US market for recent twelve months ending July 2012. The company has released the
The US Food and Drug Administration (FDA) has approved AstraZeneca’s Imfinzi (durvalumab) in combination with Padcev (enfortumab vedotin) for adult patients with muscle-invasive bladder cancer (MIBC) who cannot receive or have refused cisplatin-based chemotherapy.